Celcuity Inc.
CELC · XNASCIK 1603454fmd_1EGK11XXF6NPDQZ6RZ6R1AB712Services · Services-Medical LaboratoriesTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2026, 41 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 3 | 5 | 6 | 6 | 8 | 26 | 35 | 61 | 104 | 145 |
| Total operating expenses | 3 | 6 | 8 | 8 | 10 | 28 | 39 | 66 | 113 | 172 |
| Operating income | (3) | (6) | (8) | (8) | (10) | (28) | (39) | (66) | (113) | (172) |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 5 | 10 | 17 |
| Interest and investment income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 8 | 12 | 12 |
| Other non-operating income (expense) | 0 | (0) | 0 | 0 | 0 | (1) | (1) | 2 | 1 | (5) |
| Income before taxes | (3) | (6) | (7) | (7) | (9) | (30) | (40) | (64) | (112) | (177) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | – | – | – | – | – |
| Net income from continuing operations | (3) | (6) | (7) | (7) | (9) | – | – | – | – | – |
| Net income | (3) | (6) | (7) | (7) | (9) | (30) | (40) | (64) | (112) | (177) |